Moreover, compared to non-COVID-19 donors, COVID-19 patients’ FX levels were elevated in the liver and serum, which is the major source and carrier of FXa, respectively (Fig. 1b, c and Supplementary Fig. 1c). The gene discussed is F10; the disease is COVID-19.